Sequana Medical announces the completion of alfapump

Reporting of primary endpoint on track for Q4 2022FDA regulatory submission on track for mid-202370% survival of POSEIDON Roll-In patients at one year...

Related Keywords

Norway ,Australia ,United States ,New Zealand ,Hong Kong ,United Kingdom ,Israel ,Belgium ,China ,Canada ,Switzerland ,American ,Kaplan Meier ,Cian Crosbie ,Gijs Klarenbeek ,Guillaume Van Renterghem ,Company Or Sequana ,Clinical Events Committee ,Liver International ,Sequana Medical ,Euronext Brussels ,North American ,Pivotal Cohort ,Roll In Cohort ,Chief Executive Officer ,Senior Medical Adviser ,Clinical Events ,Direct Sodium Removal ,Sequana Medical Nv ,